Protein assays for diagnosis of Wiskott-Aldrich syndrome and X-linked thrombocytopenia

British Journal of Haematology

Volumn 113, Issue 4, 2001, Pages 861-865

  Qasim, Waseem ^a   Gilmour, Kimberly C ^a,b   Heath, Stephanie ^c   Ashton, Eleanor ^a   Cranston, Treena ^b   Thomas, Angela ^d   Finn, Adam ^e   Graham Davies, E ^a,b   Thrasher, Adrian J ^a,b   Kinnon, Christine ^b   Jones, Alison ^a,b   Gaspar, Hubert B ^a,f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Great Ormond Street Hospital NHS Trust ^*  (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d NHS LOTHIAN   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Immunoblotting; Protein assays; Wiskott Aldrich syndrome; Wiskott Aldrich syndrome protein; X linked thrombocytopenia

Indexed keywords

WISKOTT ALDRICH SYNDROME PROTEIN;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMMUNOBLOTTING; INFANT; INTERMETHOD COMPARISON; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; THROMBOCYTOPENIA; VALIDATION PROCESS; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKED DISORDER;

AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOBLOTTING; INFANT; MALE; MIDDLE AGED; MUTATION; PROTEINS; THROMBOCYTOPENIA; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN; X CHROMOSOME;

EID: 0034943052     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02832.x     Document Type: Article

References (17)

1. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome
2. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia
3. Limitations in the use of SSCP analysis
4. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): The use of protein analysis as a diagnostic indicator of XLA
5. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression
6. Rapid protein based assays for the diagnosis of T-B+ severe combined immunodeficiency
7. Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients
8. Variable expression of WASP in B cell lines of Wiskott-Aldrich syndrome patients
9. WASP levels in platelets and lymphocytes of Wiskott-Aldrich syndrome patients correlate with cell dysfunction
10. WASPbase: A database of WAS- and XLT-causing mutations
11. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization
12. The Wiskott-Aldrich syndrome
13. Flow cytometric analysis of Wiskott-Aldrich syndrome (WAS) protein in lymphocytes from WAS patients and their familial carriers
14. Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells
15. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene
16. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype